Trang chủ / Tin tức / Khoa học & công nghệ
Khoa học & công nghệ

Prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: real-world data from Vietnam

07/11/2026 · Thành viên: ÔNG. NGUYỄN HỒNG LONG · Nguồn: OpenAlex

Abstract Background Atezolizumab plus bevacizumab is the standard-of-care systemic regimen for advanced hepatocellular carcinoma (HCC). Accessible prognostic indicators are valuable in real-world p...

<p><strong>Tác giả:</strong> Tuan Anh Pham, Thi Thu Huong Nguyen, Thang Vu Hong, Quốc Hoàn Chử, Thi Yen Le, Xuan Dai Nguyen, Quang Huy Do, Van Quang Le, Duy Manh Pham</p>

<p>Abstract Background Atezolizumab plus bevacizumab is the standard-of-care systemic regimen for advanced hepatocellular carcinoma (HCC). Accessible prognostic indicators are valuable in real-world practice, particularly in populations with a high burden of hepatitis B virus (HBV). Objective To evaluate the prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) and determine a pragmatic, clinically interpretable threshold for risk stratification. Materials and methods This retros...</p>

<p>📄 DOI: <a href="https://doi.org/https://doi.org/10.1186/s12876-026-05507-9" target="_blank" rel="noopener">https://doi.org/10.1186/s12876-026-05507-9</a></p>

<p>📖 <a href="https://doi.org/https://doi.org/10.1186/s12876-026-05507-9" target="_blank" rel="noopener">Xem bài báo đầy đủ</a></p>

Bài viết được biên soạn lại bởi LIFVietnam. Nguồn tham khảo: OpenAlex